MUSTGROW BIOLOGICS CORP - MGROF STOCK NEWS

MustGrow has received California registration and organic approval for its TerraSanteTM biofertility product. The approval allows sales of the organic product in California and signifies an important step in the company's commercialization strategy. TerraSanteTM focuses on soil microbiome health, nutrient efficiency, and plant yields, positioning it well in the organic agriculture market. MustGrow expects to expand its state-level registrations in the U.S., following successful registrations in California, Oregon, and Washington State. The product complements the company's existing biocontrol programs and targets key crops in California's agriculture market.

MustGrow Biologics Corp. has signed an exclusive distribution agreement with G.S. Long Co., Inc. for its TerraSanteTM biofertility product in Oregon and Washington State. TerraSanteTM is organic certified through the USDA National Organic Program, focusing on soil microbiome health, nutrient/water efficiencies, and plant yields. The agreement marks a significant milestone in MustGrow's commercialization strategy. G.S. Long Company is a well-established agricultural retailer with crop consultant capabilities, extending MustGrow's reach in the market. Sales in both states will be authorized under existing product registrations, with plans for further state-level registrations. Oregon and Washington present a strong market opportunity for organic produce, aligning with MustGrow's goals of sustainable agriculture practices.

MustGrow Biologics Corp. will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024, with one-on-one meetings scheduled for May 2, 2024. Colin Bletsky, the COO, will host the presentation. Investors can access the live webcast for the presentation and book 1x1 meetings with the company. The event will take place at the Paris Hotel & Casino in Las Vegas, NV.

MustGrow Biologics Corp. has received approval to commence sales of TerraSanteTM, an organic biofertility product, in Oregon State. The product focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields. MustGrow's organic compliance certification from the USDA National Organic Program will apply to this Registration. TerraSanteTM product sales may now commence in Oregon State, with a sales and marketing commercialization strategy already underway. The organic biofertility product will complement the Company's existing biocontrol programs, currently under development with four global partners. MustGrow believes its organic TerraSanteTM product will position Oregon farmers to meet increasing demand for organic, local, and healthy produce.

MustGrow Biologics Corp. (MGRO) Provides Additional Information

MustGrow Biologics Corp. (MGRO) signs a collaboration agreement with Bayer AG (BAYN) for soil applications of mustard-based biocontrol technologies in Europe, Middle East, and Africa. MustGrow will receive upfront license fees, milestone payments, royalties, and manufacturing sales linked to development and commercial achievements. The agreement could approximate USD $35 to $40 million over the next several years.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) has received the Washington State Department of Agriculture Fertilizer Registration Certificate for TerraSanteTM, its mustard plant-based crop fertilizer and soil amendment product. The product has also been awarded organic compliance certification from the USDA National Organic Program (OMRI Listed®). TerraSanteTM focuses on soil microbiome health, nutrient/water use efficiencies, and plant yields, with a commercialization strategy already forming for the 2024 planting season.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) announces Corey Giasson, President & CEO, will present live at the Global SMID Cap Investor Conference on November 16th, 2023. The event will be interactive, allowing investors to ask questions in real time, with an archived webcast available afterward. Pre-registration is recommended for expedited participation.

MustGrow Biologics Corp. has received approval from Health Canada's Pest Management Regulatory Agency to begin large-scale field trials for its TerraMG™ mustard-derived soil biopesticide technology. The trials will focus on Canadian canola and pulse crop markets as part of NexusBioAg's 2024 BioAdvantage Trials Program. This program will evaluate the efficacy and commercial potential of TerraMGTM.